Left Main and Multi-Vessel Coronary Disease: Should You Ever Call a Surgeon?
At the 2015 San Diego Cardiovascular Interventions Course, Dr. Michael Ragosta, Director of the Cardiac Catheterization Laboratory and Professor of Medicine/Cardiology, University of Virginia Health System, Charlottesville, VA at the San Diego gave a presentation titled “Left Main and Multi-Vessel Coronary Disease: Should You Ever Call a Surgeon?”
Dr. Ragosta provided a comprehensive review of the decision-making process involved in evaluating and developing the best treatment plan for each patient with advanced coronary artery disease. He recommended calling a surgeon and using the heart team approach, which is a multidisciplinary team consisting of interventional cardiologists and cardiothoracic surgeons who critically evaluate the clinical situation of each patient. Individual clinical evaluations include reviewing the angiographic and clinical characteristics, calculating the STS risk score and the Syntax score, identifying diabetes, and evaluating the likelihood of complete revascularization. Complete revascularization is important because it can improve outcomes in certain patients.
Dr. Ragosta reviewed the guidelines for unprotected left main disease and demonstrated how the heart team can use this clinical information to determine the best treatment for patients—PCI, CABG or a hybrid approach for revascularization. Dr. Ragosta concluded that the best decisions are made with a heart team.
- Listen to Dr. Ragosta’s presentation entitled “Left Main and Multi-Vessel Coronary Disease: Should You Ever Call a Surgeon?”
- Learn more about the clinical data associated with Protected PCI.
To learn more about the Impella® platform of heart pumps, including important risk and safety information associated with the use of the devices, please visit: abiomed.com/important-safety-information